406 related articles for article (PubMed ID: 18849616)
1. Safety and immunogenicity of a cluster specific immunotherapy in children with bronchial asthma and mite allergy.
Schubert R; Eickmeier O; Garn H; Baer PC; Mueller T; Schulze J; Rose MA; Rosewich M; Renz H; Zielen S
Int Arch Allergy Immunol; 2009; 148(3):251-60. PubMed ID: 18849616
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of serum IgG4 antibodies specific to grass pollen allergen components in the follow up of allergic patients undergoing subcutaneous and sublingual immunotherapy.
Rossi RE; Monasterolo G; Coco G; Silvestro L; Operti D
Vaccine; 2007 Jan; 25(5):957-64. PubMed ID: 17045368
[TBL] [Abstract][Full Text] [Related]
3. Specific allergen immunotherapy: effect on immunologic markers and clinical parameters in asthmatic children.
Cevit O; Kendirli SG; Yilmaz M; Altintas DU; Karakoc GB
J Investig Allergol Clin Immunol; 2007; 17(5):286-91. PubMed ID: 17982919
[TBL] [Abstract][Full Text] [Related]
4. Specific IgG4 production during house dust mite immunotherapy among age, gender and allergic disease populations.
Lai X; Li J; Xiao X; Liu E; Zhang C; Wang H; Gjesing B; Zhong N; Spangfort MD
Int Arch Allergy Immunol; 2013; 160(1):37-46. PubMed ID: 22948109
[TBL] [Abstract][Full Text] [Related]
5. Analysis of basophil activation by flow cytometry in pediatric house dust mite allergy.
González-Muñoz M; Villota J; Moneo I
Pediatr Allergy Immunol; 2008 Jun; 19(4):342-7. PubMed ID: 18266832
[TBL] [Abstract][Full Text] [Related]
6. The effect of oral steroids with and without vitamin D3 on early efficacy of immunotherapy in asthmatic children.
Majak P; Rychlik B; Stelmach I
Clin Exp Allergy; 2009 Dec; 39(12):1830-41. PubMed ID: 19817753
[TBL] [Abstract][Full Text] [Related]
7. Effect of allergen-specific immunotherapy on plasma level of platelet factor 4 (PF-4) and beta-thromboglobulin (beta-TG), platelet activation markers in patients with house dust mite allergy.
Kasperska-Zajac A; Brzoza Z; Rogala B
Vaccine; 2007 May; 25(18):3595-8. PubMed ID: 17291641
[TBL] [Abstract][Full Text] [Related]
8. [Effect of 1-year specific immunotherapy with standardized house dust mite vaccine on mild to moderate allergic asthmatic patients].
Wang HY; Lin XP; Hao CL; Zhang CQ; Sun BQ; Zheng JP; Chen P; Sheng JY; Wu A; Zhong NS
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Oct; 29(10):679-87. PubMed ID: 17129496
[TBL] [Abstract][Full Text] [Related]
9. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
[TBL] [Abstract][Full Text] [Related]
10. Induction of T 'regulatory' cells by standardized house dust mite immunotherapy: an increase in CD4+ CD25+ interleukin-10+ T cells expressing peripheral tissue trafficking markers.
Gardner LM; Thien FC; Douglass JA; Rolland JM; O'Hehir RE
Clin Exp Allergy; 2004 Aug; 34(8):1209-19. PubMed ID: 15298560
[TBL] [Abstract][Full Text] [Related]
11. Induction of CD4+CD25+Foxp3+IL-10+ T cells in HDM-allergic asthmatic children with or without SIT.
Wei W; Liu Y; Wang Y; Zhao Y; He J; Li X; Shen K
Int Arch Allergy Immunol; 2010; 153(1):19-26. PubMed ID: 20357481
[TBL] [Abstract][Full Text] [Related]
12. Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study.
Lue KH; Lin YH; Sun HL; Lu KH; Hsieh JC; Chou MC
Pediatr Allergy Immunol; 2006 Sep; 17(6):408-15. PubMed ID: 16925685
[TBL] [Abstract][Full Text] [Related]
13. Effects of dermatophagoides pteronyssinus allergen-specific immunotherapy on the serum interleukin-13 and pulmonary functions in asthmatic children.
Chen ZG; Li M; Chen YF; Ji JZ; Li YT; Chen W; Chen FH; Chen H
Chin Med J (Engl); 2009 May; 122(10):1157-61. PubMed ID: 19493463
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of long-term sublingual immunotherapy as an adjunct to pharmacotherapy in house dust mite-allergic children with asthma.
Ozdemir C; Yazi D; Gocmen I; Yesil O; Aydogan M; Semic-Jusufagic A; Bahceciler NN; Barlan IB
Pediatr Allergy Immunol; 2007 Sep; 18(6):508-15. PubMed ID: 17680909
[TBL] [Abstract][Full Text] [Related]
15. Depigmented and polymerised house dust mite allergoid: allergen content, induction of IgG4 and clinical response.
Gallego MT; Iraola V; Himly M; Robinson DS; Badiola C; García-Robaina JC; Briza P; Carnés J
Int Arch Allergy Immunol; 2010; 153(1):61-9. PubMed ID: 20357486
[TBL] [Abstract][Full Text] [Related]
16. [Clinical efficacy of a standardized specific immunotherapy against house dust mite in 85 asthmatic children].
Zhang X; Li MR; Wang C; Wang XN; Zhang HL; Lin J; Jin K; Li YC
Zhonghua Er Ke Za Zhi; 2010 Jul; 48(7):526-30. PubMed ID: 21055090
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the long-term efficacy of 3- and 5-year house dust mite allergen immunotherapy.
Stelmach I; Sobocińska A; Majak P; Smejda K; Jerzyńska J; Stelmach W
Ann Allergy Asthma Immunol; 2012 Oct; 109(4):274-8. PubMed ID: 23010234
[TBL] [Abstract][Full Text] [Related]
18. [Urticaria in relation to mite sensitivity and immunotherapy with Injection dermatophagoidei farinae].
Xing DR; Wen TH; Yu YL; Wei ZP; Li YM; Han T
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2008 Dec; 26(6):422-7. PubMed ID: 19288915
[TBL] [Abstract][Full Text] [Related]
19. Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention.
Halken S
Pediatr Allergy Immunol; 2004 Jun; 15 Suppl 16():4-5, 9-32. PubMed ID: 15125698
[TBL] [Abstract][Full Text] [Related]
20. Comparison between the use of adsorbed and aqueous immunotherapy material in Dermatophagoides pteronyssinus sensitive asthmatic children.
Altintaş D; Akmanlar N; Güneşer S; Burgut R; Yilmaz M; Buğdayci R; Aksungur P
Allergol Immunopathol (Madr); 1999; 27(6):309-17. PubMed ID: 10611556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
